VIOLIN Logo
VO Banner
Search: for Help
About
Introduction
Statistics
VIOLIN News
Your VIOLIN
Register or Login
Submission
Tutorial
Vaccine & Components
Vaxquery
Vaxgen
VBLAST
Protegen
VirmugenDB
DNAVaxDB
CanVaxKB
Vaxjo
Vaxvec
Vevax
Huvax
Cov19VaxKB
Host Responses
VaximmutorDB
VIGET
Vaxafe
Vaxar
Vaxism
Vaccine Literature
VO-SciMiner
Litesearch
Vaxmesh
Vaxlert
Vaccine Design
Vaxign2
Vaxign
Community Efforts
Vaccine Ontology
ICoVax 2012
ICoVax 2013
Advisory Committee
Vaccine Society
Vaxperts
VaxPub
VaxCom
VaxLaw
VaxMedia
VaxMeet
VaxFund
VaxCareer
Data Exchange
V-Utilities
VIOLINML
Help & Documents
Publications
Documents
FAQs
Links
Acknowledgements
Disclaimer
Contact Us
UM Logo

p67

Gene Name p67
Sequence Strain (Species/Organism) Theileria parva strain Mugaga
VO ID VO_0011183
NCBI Protein GI 4106806
Other Database IDs CDD:253298
Taxonomy ID 5875
Gene Strand (Orientation) +
Protein Name p67 surface antigen
Protein pI 4.7
Protein Weight 70967
Protein Length 771
Protein Note Sporozoite P67 surface antigen; pfam05642
Protein Sequence
>AAD03021.1 p67 surface antigen [Theileria parva]
MQITQFLLIIPVFFVSAGDKMPTEEQPFPSRLGPLVTLESAITQPTPVYTMRTVGNVSKAAKVWKSAVSS
PDVSTTILTPVSEENITSTLQTQTEEVPAASGSDSSRATNLVQTQSQVQDNVKQQQDTKGNRSDSEEENE
DGTLSTDVSPAIPTPVSEEIITPTLQAQTKEEVPPADLSDQVPSNGSDSEEEDEDSSLGTDERGLKKTLP
PGKTSTGETTSDQDLKTKQQKNGVSGPAGGSHSSGLKVPGLGVPGEVSPQGGQSLASNTSREGQTQHHQV
RDGDGRVIEPKIGLPGPPSAPEPSPGAPGIKVRESGNRAMDIVQFLGRFRPEPRAYEGERTNVAELKKFL
FEELESLVNTLIELKLAIANDFVEITDGLRKNTKDHEARLKLLTGVEFTKRKSAANVVKGFSSLYCVLLM
NMNVIKEKTKESEVADGIWKLSTIPDKVANELLLAMEKIVVPPKTPELDEAFKEIEFGFKIAYYATKDIL
SSIENTVHNLMHAKNYEENFIAQVRNSLRMVPHQMNLTESSFVIKISDMMRRRGTASQDEPAGAGSGVTP
GRGSSGTPGAAGTGGGSLRGFDLSEEEVKKILDEIVKDPSDGELGLGDLSDPSGRSSGRQPSLGPSLGIT
DGQAGPTIVSPTGPTIAAGGEQPPSAPNGTATGPAGTQPEGGEKKEGLIQKLKKKLLGSGFEVASLMIPM
ATIIISIVH

Molecule Role Protective antigen
Molecule Role Annotation Immunization with recombinant forms of a sporozoite surface antigen (r-p67), derived from either bacterial or insect cells, induces high levels of sporozoite neutralizing antibodies in cattle.In vivo immunization studies have shown that approximately 30% of immunized cattle are nonreactors to a needle LD70 sporozoite challenge, 40% experience a mild disease reaction from which they recover, and the remaining 30% suffer severe disease and are clinically indistinguishable from controls. Transient parasitosis and mild clinical reactions are also observed in challenge of cattle immunized by infection and treatment and such responses constitute immunity to ECF. Hence, p67 is able to routinely induce immunity at a level of about 70% (Morzaria et al., 2000).
Related Vaccines(s) T. parva Subunit p67 Protein Vaccine
References